Nicholas A Butowski Selected Research

Nicholas A Butowski Research Topics

22	Glioblastoma (Glioblastoma Multiforme) 10/2022 - 04/2006
17	Neoplasms (Cancer) 01/2022 - 03/2006
11	Glioma (Gliomas) 01/2022 - 03/2006
3	Brain Neoplasms (Brain Tumor) 01/2021 - 03/2006
2	Disease Progression 01/2016 - 09/2010
2	Lymphopenia (Lymphocytopenia) 01/2014 - 08/2010
1	Vision Disorders (Hemeralopia) 07/2021
1	Oligodendroglioma 07/2021
1	Cognitive Dysfunction 07/2021
1	Intraoperative Complications 08/2017
1	Malignant Mesothelioma 12/2016
1	Meningioma (Meningiomas) 12/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2016
1	Neurocytoma 01/2016
1	Wounds and Injuries (Trauma) 06/2011
1	Infections 06/2011
1	Vascular Remodeling 01/2011
1	Fatigue 08/2010
1	Thrombocytopenia (Thrombopenia) 08/2010
1	Leukopenia 08/2010
1	Hemorrhage 08/2010
1	Carcinogenesis 04/2006
1	Necrosis 03/2006
1	Astrocytoma (Pilocytic Astrocytoma) 03/2006

10	Bevacizumab (Avastin)FDA Link 01/2022 - 06/2011
5	Pharmaceutical PreparationsIBA 01/2021 - 09/2010
4	Temozolomide (Temodar)FDA LinkGeneric 08/2015 - 09/2010
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 07/2014
2	Angiogenesis InhibitorsIBA 01/2011 - 08/2010
1	carotuximabIBA 01/2022
1	infigratinibIBA 01/2022
1	poly ICLCIBA 01/2022
1	VaccinesIBA 01/2022
1	InterferonsIBA 01/2019
1	pembrolizumabIBA 01/2019
1	palbociclibIBA 11/2018
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 03/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2017
1	Biological ProductsIBA 12/2016
1	AntigensIBA 12/2016
1	MesothelinIBA 12/2016
1	2,2- dimethyl- N- (6- oxo- 6,7- dihydro- 5H- dibenzo(b,d)azepin- 7- yl)- N'- (2,2,3,3,3- pentafluoropropyl)malonamideIBA 12/2016
1	SaltsIBA 01/2016
1	O(6)-Methylguanine-DNA MethyltransferaseIBA 09/2014
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2014
1	ErbB Receptors (EGF Receptor)IBA 07/2014
1	Peptides (Polypeptides)IBA 01/2014
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2014
1	Indicators and Reagents (Reagents)IBA 01/2011
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 08/2010
1	pazopanib FDA Link 08/2010
1	Tyrosine Kinase InhibitorsIBA 08/2010
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 08/2010

12	Therapeutics 10/2022 - 03/2006
6	Drug Therapy (Chemotherapy) 07/2021 - 04/2006
5	Radiotherapy 07/2021 - 03/2006
4	Immunotherapy 01/2022 - 01/2014
2	Re-Irradiation 09/2019 - 03/2006
2	Aftercare (After-Treatment) 05/2019 - 09/2013
2	Craniotomy 02/2012 - 06/2011
1	Adjuvant Chemotherapy 07/2021
1	Chemoradiotherapy 08/2017
1	Adjuvant Radiotherapy 01/2016
1	Duration of Therapy 06/2011
1	Drug Tapering 08/2010
1	Photochemotherapy (Photodynamic Therapy) 03/2006
1	Brachytherapy 03/2006
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 03/2006